Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the efficacy of direct oral anticoagulants (DOACs) in comparison to warfarin in morbidly obese patients

Published:2019-08-08 Issue:4 Volume:47 Page:181-185
ISSN:2154-8331
Container-title:Hospital Practice
language:en
Short-container-title:Hospital Practice

Author:

Kalani Charlene¹,Awudi Elizabeth¹,Alexander Thomas¹²,Udeani George¹³,Surani Salim¹⁴⁵⁶

Affiliation:

1. Pharmacy, Corpus Christi Medical Center, Corpus Christi, TX, USA

2. Cardiology, Corpus Christi Medical Center, Corpus Christi

3. Texas Rangel College of Pharmacy, Texas A&M University, Kingsville, TX, USA

4. Pulmonology/Critical Care, Corpus Christi Medical Center, Corpus Christi, TX, USA

5. College of Medicine, Texas A&M University, College Station, TX, USA

6. College of Medicine, University of North Texas, Denton, TX, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/21548331.2019.1674586

Reference21 articles.

1. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation

2. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH

3. The non-vitamin K antagonist oral anticoagulants (NOACs) and extremes of body weight—a systematic literature review

4. Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era

5. Relative efficacy and safety of non-Vitamin K oral anticoagulants for non-valvular atrial fibrillation: Network meta-analysis comparing apixaban, dabigatran, rivaroxaban and edoxaban in three patient subgroups

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Direct Oral Anticoagulants versus Warfarin in Obese Patients (BMI ≥ 30 kg/m2) with Atrial Fibrillation or Venous Thromboembolism: An Updated Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-06-27

2. A Real-World Comparison of Apixaban and Rivaroxaban in Obese and Morbidly Obese Patients With Nonvalvular Atrial Fibrillation;Journal of Pharmacy Practice;2023-09-15

3. Quality-by-Design-Based Development of Rivaroxaban-Loaded Liquisolid Compact Tablets with Improved Biopharmaceutical Attributes;AAPS PharmSciTech;2023-08-28

4. DOAC compared with warfarin for VTE in patients with obesity: a retrospective cohort study conducted through the VENUS network;Journal of Thrombosis and Thrombolysis;2023-02-09

5. Comparative pharmacology of direct oral anticoagulants and vitamin K antagonist;2022-11-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3